Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Print PDF (507K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Childs, K. S.
Right arrow Articles by Goodbourn, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Childs, K. S.
Right arrow Articles by Goodbourn, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 2003, Vol. 31, No. 12 3016-3026
© 2003 Oxford University Press

Identification of novel co-repressor molecules for Interferon Regulatory Factor-2

Kay S. Childs and Stephen Goodbourn

Department of Biochemistry and Immunology, St George’s Hospital Medical School, University of London, London SW17 0RE, UK

*To whom correspondence should be addressed. Tel: +44 0208 725 5942; Fax: +44 0208 725 2992; Email: s.goodbourn{at}sghms.ac.uk

We have identified two novel proteins that interact specifically with the C-terminal repression domain of Interferon Regulatory Factor-2 (IRF-2). These proteins, which we term IRF-2 binding proteins 1 and 2 (IRF-2BP1 and IRF-2BP2, the latter having two splicing isoforms, A and B), are nuclear proteins, and have the properties of IRF-2-dependent transcriptional co-repressors that can inhibit both enhancer-activated and basal transcription in a manner that is not dependent upon histone deacetylation. IRF-2BP1 and IRF-2BP2A/B contain an N-terminal zinc finger and a C-terminal RING finger domain of the C3HC4 subclass, but show no homology to other known transcriptional regulators; they therefore define a new family of co- repressor proteins. An alternatively spliced form of IRF-2 that lacks two amino acids (valines 177 and 178) in the central portion of the protein (IRF-2[S]) cannot bind to these co-repressors and cannot mediate repression despite having the same C- terminal repression domain as IRF-2, suggesting that the relative conformation of the DNA binding domain and the C-terminal region of IRF-2 is crucial for transcriptional repression.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
A. A. Tinnikov, K. T. Yeung, S. Das, and H. H. Samuels
Identification of a Novel Pathway That Selectively Modulates Apoptosis of Breast Cancer Cells
Cancer Res., February 15, 2009; 69(4): 1375 - 1382.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. Koeppel, S. J. van Heeringen, L. Smeenk, A. C. Navis, E. M. Janssen-Megens, and M. Lohrum
The novel p53 target gene IRF2BP2 participates in cell survival during the p53 stress response
Nucleic Acids Res., February 1, 2009; 37(2): 322 - 335.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
F. Liu
PCTA: A New Player in TGF-{beta} Signaling
Sci. Signal., November 18, 2008; 1(46): pe49 - pe49.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M.-C. Chung and S. Kawamoto
IRF-2 Is Involved in Up-regulation of Nonmuscle Myosin Heavy Chain II-A Gene Expression during Phorbol Ester-induced Promyelocytic HL-60 Differentiation
J. Biol. Chem., December 31, 2004; 279(53): 56042 - 56052.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.